Gynecologic Malignancies


Share

Program Content

Activities

  • RUBY dMMR Post Hoc Analysis
    RUBY Post Hoc Analysis: Survival Outcomes With Dostarlimab Plus Chemotherapy by Type of MMR Deficiency in Patients With Endometrial Cancer
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 25, 2024

    Expires: June 24, 2025

  • PACS
    PACS: Sintilimab Plus Paclitaxel and Cisplatin as Neoadjuvant Treatment for FIGO Stage IB3 and IIA2 Cervical Cancer
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 27, 2024

    Expires: June 26, 2025

  • Immunotherapy Advances in Gynecologic Cancers
    Immunotherapy Advances in Gynecologic Cancers: Insights From ASCO 2024
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 01, 2024

    Expires: January 31, 2025

Faculty

cover img faculity

Kathleen N. Moore, MD, MS, FASCO

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director, Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from GSK.

GSK